Apollon Wealth Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Apollon Wealth Management’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$864K	Buy	60,197 +13,102	+28%	+$195K	0.01%	658
2025 Q4	$709K	Buy	47,095 +13,012	+38%	+$195K	0.01%	705
2025 Q3	$491K	Buy	34,083 +10,194	+43%	+$145K	0.01%	834
2025 Q2	$341K	Buy	+23,889	New	+$341K	0.01%	964

Other funds holding BMEZ

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Apollon Wealth Management's BMEZ Position: Q1 2026 in Review

Apollon Wealth Management increased its BlackRock Health Sciences Trust II (BMEZ) stake by 28% in Q1 2026, buying an estimated $195K and bringing the position to 60,197 shares worth $864K. The position accounts for 0.01% of the portfolio, ranked #658.

Apollon Wealth Management first reported a position in BMEZ in Q2 2025 and has held it in 4 quarters since. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

Apollon Wealth Management held 60,197 shares of BlackRock Health Sciences Trust II worth $864K as of Q1 2026.
Apollon Wealth Management bought 13,102 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $195K.
BlackRock Health Sciences Trust II made up 0.01% of Apollon Wealth Management's portfolio in Q1 2026, its #658 holding.
Apollon Wealth Management first reported a position in BlackRock Health Sciences Trust II in Q2 2025 and has held it in 4 quarters since.
88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Apollon Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.